6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	GreenPower Unveils Innovative Heating Solution for Type A Nano BEAST All-Electric, Purpose-Built, Zero-Emission School Bus
8m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
13m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
18m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
18m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

About

6.59USD+0.16 +2.49%

Closed • Updated at 13:34 GMT+00:00

Market Cap$433.98M

Volume777.6K

Beta0.66

RSI69.60

Gross Margin64.38%

Health TechnologyPharmaceuticals: Major

Evolus, Inc. Common Stock — investor relations, events, news, and company updates on 6ix.

Latest News

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

Evolus to Report First Quarter Financial Results on May 4, 2026

Telix Appoints David Gill as Non-Executive Director

Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference

Community Chat

Ask AI